ISRCTN18249297已完成未知
euraminidase inhibitor prescribing by physicians in the UK: a questionnaire-based survey of practice
niversity Hospitals Southampton Foundation NHS trust0 个研究点目标入组 237 人开始时间: 2015年10月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 237
研究概览
简要总结
2021 results in https://doi.org/10.1016/j.clinpr.2021.100075 (added 10/05/2021)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. A hospital-based physician (consultant or specialist registrar grade or equivalent)
- •2. Working in the UK and managing patient with suspected influenza
- •3. Working in infectious diseases, microbiology, respiratory medicine, acute medicine, emergency medicine or geriatric medicine
排除标准
- •Not meeting any of the inclusion criteria
研究者
相似试验
已完成
不适用
Efficacy of oral erdosteine ??in patients with acute rhinosinusitisKCT0004649Inha University Hospital30
终止
1 期
Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic EffectsHealthy ParticipantsNCT05604287IlDong Pharmaceutical Co Ltd67
终止
1 期
Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19Covid19NCT04803227Histogen13
已完成
2 期
Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative ColitisUlcerative ColitisNCT02447302Arena Pharmaceuticals156
撤回
1 期
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic TumorsThoracic TumorsSmall Cell Lung CancerNon-small Cell Lung CancerNCT04841538Elpiscience Biopharma, Ltd.